U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C152H232N40O45
Molecular Weight 3339.7095
Optical Activity UNSPECIFIED
Defined Stereocenters 29 / 29
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TASPOGLUTIDE

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC4=CN=CN4)C(C)O)C(C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC5=CNC6=C5C=CC=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O

InChI

InChIKey=WRGVLTAWMNZWGT-VQSPYGJZSA-N
InChI=1S/C152H232N40O45/c1-20-78(10)119(145(233)168-81(13)125(213)174-105(63-87-66-162-92-39-28-27-38-90(87)92)134(222)176-101(59-75(4)5)135(223)187-117(76(6)7)143(231)173-95(41-30-32-56-154)142(230)192-152(18,19)148(236)184-93(122(157)210)42-33-57-161-150(158)159)189-136(224)103(60-84-34-23-21-24-35-84)177-131(219)99(50-54-115(206)207)172-130(218)94(40-29-31-55-153)170-124(212)80(12)166-123(211)79(11)167-129(217)98(47-51-110(156)199)169-111(200)68-163-127(215)96(48-52-113(202)203)171-132(220)100(58-74(2)3)175-133(221)102(62-86-43-45-89(198)46-44-86)178-139(227)107(70-193)181-141(229)109(72-195)182-144(232)118(77(8)9)188-138(226)106(65-116(208)209)179-140(228)108(71-194)183-147(235)121(83(15)197)190-137(225)104(61-85-36-25-22-26-37-85)180-146(234)120(82(14)196)186-112(201)69-164-128(216)97(49-53-114(204)205)185-149(237)151(16,17)191-126(214)91(155)64-88-67-160-73-165-88/h21-28,34-39,43-46,66-67,73-83,91,93-109,117-121,162,193-198H,20,29-33,40-42,47-65,68-72,153-155H2,1-19H3,(H2,156,199)(H2,157,210)(H,160,165)(H,163,215)(H,164,216)(H,166,211)(H,167,217)(H,168,233)(H,169,200)(H,170,212)(H,171,220)(H,172,218)(H,173,231)(H,174,213)(H,175,221)(H,176,222)(H,177,219)(H,178,227)(H,179,228)(H,180,234)(H,181,229)(H,182,232)(H,183,235)(H,184,236)(H,185,237)(H,186,201)(H,187,223)(H,188,226)(H,189,224)(H,190,225)(H,191,214)(H,192,230)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H4,158,159,161)/t78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,117-,118-,119-,120-,121-/m0/s1

HIDE SMILES / InChI
Taspoglutide is a glucagon-like peptide-1 agonist was studied in phase III clinical trials for the treatment patients with type 2 diabetes. However, in September 2010 Roche halted Phase III clinical trials due to gastrointestinal intolerability and serious hypersensitivity reactions experienced by some trial participants.

Approval Year

PubMed

PubMed

TitleDatePubMed
Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.
2009 Jul
Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects.
2015 Nov 1

Sample Use Guides

taspoglutide 10mg sc weekly
Route of Administration: Other
Name Type Language
TASPOGLUTIDE
INN   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
RO5073031
Code English
R-1583
Code English
[8-(2-Amino-2-methylpropanoic acid),35-(2-amino-2-methylpropanoic acid)]human glucagon-like peptide 1 (GLP-1)-(7-36)-peptidamide
Common Name English
7-36-GLUCAGON-LIKE PEPTIDE I (HUMAN), 8-(2-METHYLALANINE)-35-(2-METHYLALANINE)-36-L-ARGININAMIDE-
Common Name English
BIM51077
Code English
taspoglutide [INN]
Common Name English
R1583
Code English
TASPOGLUTIDE [USAN]
Common Name English
Taspoglutide [WHO-DD]
Common Name English
TASPOGLUTIDE [MI]
Common Name English
RO-5073031
Code English
BIM-51077
Code English
Classification Tree Code System Code
NCI_THESAURUS C98085
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
Code System Code Type Description
EVMPD
SUB32528
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
PUBCHEM
56842233
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
NCI_THESAURUS
C152518
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
MERCK INDEX
m10479
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY Merck Index
MESH
C541736
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
FDA UNII
2PHK27IP3B
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
INN
8975
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
CAS
275371-94-3
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
WIKIPEDIA
TASPOGLUTIDE
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
DRUG BANK
DB14027
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107860
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY
USAN
WW-10
Created by admin on Fri Dec 15 16:00:23 GMT 2023 , Edited by admin on Fri Dec 15 16:00:23 GMT 2023
PRIMARY